Corpus ID: 201663422

Inhibition of the Cell Growth in M Cells by Bi-Para

@inproceedings{Andres2019InhibitionOT,
  title={Inhibition of the Cell Growth in M Cells by Bi-Para},
  author={F. Andres and L. Iamele and Timo Mey and Jakob C St{\"u}ber and Florian Kast and E. Gherardi and H. Niemann and A. Pl{\"u}ckthun},
  year={2019}
}
  • F. Andres, L. Iamele, +5 authors A. Plückthun
  • Published 2019
    • MET, the product of the c-MET proto-oncogene, and its ligand hepatocyte growth factor/scatter factor (HGF/SF) control survival, proliferation andmigration during development and tissue regeneration. HGF/SF-MET signaling is equally crucial for growth and metastasis of a variety of human tumors, but resistance to small-molecule inhibitors of MET kinase develops rapidly and therapeutic antibody targeting remains challenging.Wemade use of the designed ankyrin repeat protein (DARPin) technology to… CONTINUE READING
    bioc.uzh.ch

    Figures from this paper

    Figures

    References

    SHOWING 1-10 OF 83 REFERENCES
    A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo.
    • 498
    • PDF
    Genetic targeting of the kinase activity of the Met receptor in cancer cells
    • 33
    • PDF
    Lung cancer cell lines harboring MET gene amplification are dependent on Met for growth and survival.
    • 298
    • PDF
    Targeting MET in cancer therapy
    • 62
    A Novel One-Armed Anti-c-Met Antibody Inhibits Glioblastoma Growth In vivo
    • 310
    • Highly Influential
    • PDF
    Characterization and structural determination of a new anti-MET function-blocking antibody with binding epitope distinct from the ligand binding domain
    • 6
    • PDF
    MetMAb, the one-armed 5D5 anti-c-Met antibody, inhibits orthotopic pancreatic tumor growth and improves survival.
    • 220
    • PDF
    Recent advances in the discovery of small molecule c-Met Kinase inhibitors.
    • 56
    Induction of hepatocyte growth factor/scatter factor by fibroblast clustering directly promotes tumor cell invasiveness.
    • 75
    • PDF
    Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752
    • G. Smolen, R. Sordella, +10 authors D. Haber
    • Biology, Medicine
    • Proceedings of the National Academy of Sciences of the United States of America
    • 2006
    • 486
    • PDF